-63% reduction from baseline at 52 weeks
3 patients still to complete 12 month trial in Q3
positive news
Ann: New positive interim data in Phase 2 study of SNT-5505, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $91.05M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.5¢ | $28.89K | 516.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 521834 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 659246 | 4 |
View Market Depth
| Last trade - 11.32am 29/07/2025 (20 minute delay) ? |
| SNT (ASX) Chart |